# Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl

> **NCT04136548** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Fentanyl
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04136548
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2020-11-18
- **Final completion:** 2020-11-18
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04136548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04136548, "Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Fentanyl". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04136548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*